These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25679296)

  • 1. Associations of fibroblast growth factor 23 and fetuin-A with coronary plaque burden and plaque composition in young adults.
    Akin F; Celik O; Ayca B; Altun I; Diker VO; Bıyık I; Siriopol D; Covic A; Kanbay M
    J Investig Med; 2015 Apr; 63(4):613-9. PubMed ID: 25679296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of fibroblast growth factor 23 and fetuin--A to coronary atherosclerosis.
    Akin F; Celik O; Altun I; Ayca B; Diker VO; Satılmıs S; Sahin C
    J Diabetes Complications; 2015; 29(4):550-5. PubMed ID: 25772252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease.
    Göçer K; Aykan AÇ; Kılınç M; Göçer NS
    Scand J Clin Lab Invest; 2020 Jul; 80(4):277-281. PubMed ID: 32077762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults.
    Celik O; Ozturk D; Akin F; Satilmis S; Yalcin AA; Erturk M; Ayca B; Akturk F; Birand A; Pusuroglu H; Kaya MG
    Coron Artery Dis; 2015 May; 26(3):266-71. PubMed ID: 25647459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
    Roos M; Lutz J; Salmhofer H; Luppa P; Knauss A; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):660-5. PubMed ID: 17970775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
    Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
    Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.
    Xiao DM; Wu Q; Fan WF; Ye XW; Niu JY; Gu Y
    Hemodial Int; 2013 Oct; 17(4):483-92. PubMed ID: 23490272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
    Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
    Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between fetuin-A levels and fibroblast growth factor 23 with the severity of coronary artery disease measured by SYNTAX scores.
    Chen YC; Lin FY; Lin RH; Chuang CL; Chang CC; Tsai CS
    Am J Cardiol; 2013 Oct; 112(7):950-3. PubMed ID: 23795812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
    Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
    Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Zhao ZW; Lin CG; Wu LZ; Luo YK; Fan L; Dong XF; Zheng H
    Biomarkers; 2013 Mar; 18(2):160-4. PubMed ID: 23410047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Correlation between Circulating Fetuin-A and Severity of Coronary Artery Disease in Men.
    Afrisham R; Paknejad M; Ilbeigi D; Sadegh-Nejadi S; Gorgani-Firuzjaee S; Vahidi M
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):338-344. PubMed ID: 32479251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease.
    Adamczyk T; Mizia-Stec K; Mizia M; Haberka M; Chmiel A; Chudek J; Gąsior Z
    Pol Arch Med Wewn; 2012; 122(1-2):14-21. PubMed ID: 22237719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease.
    Kanbay M; Wolf M; Selcoki Y; Solak Y; Ikizek M; Uysal S; Segall L; Armutcu F; Eryonucu B; Duranay M; Goldsmith D; Covic A
    Int Urol Nephrol; 2012 Aug; 44(4):1169-75. PubMed ID: 22130958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification.
    Gan F; Huang J; Dai T; Li M; Liu J
    Ann Palliat Med; 2020 Mar; 9(2):368-374. PubMed ID: 32268770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between serum levels of total bilirubin and coronary plaque vulnerability.
    Zhu KF; Wang YM; Wang YQ; Wang NF
    Coron Artery Dis; 2016 Jan; 27(1):52-8. PubMed ID: 26444254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Serum Fibroblast Growth Factor 21 and Coronary Artery Disease in Patients with Type 2 Diabetes.
    Kim WJ; Kim SS; Lee HC; Song SH; Bae MJ; Yi YS; Jeon YK; Kim BH; Kim YK; Kim IJ
    J Korean Med Sci; 2015 May; 30(5):586-90. PubMed ID: 25931789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum vitamin D levels and subclinical coronary atherosclerosis and plaque burden/composition in young adult population.
    Satilmis S; Celik O; Biyik I; Ozturk D; Celik K; Akın F; Ayca B; Yalcin B; Dagdelen S
    Bosn J Basic Med Sci; 2015 Feb; 15(1):67-72. PubMed ID: 25725147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.
    Karpouzas GA; Estis J; Rezaeian P; Todd J; Budoff MJ
    Rheumatology (Oxford); 2018 Jun; 57(6):1080-1088. PubMed ID: 29554376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 23 is associated with the presence of coronary artery disease and the number of stenotic vessels.
    Hu X; Ma X; Pan X; Hao Y; Luo Y; Lu Z; Bao Y; Jia W
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1152-7. PubMed ID: 26217893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.